Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

R-2-HG assists IDH1-mutant solid tumors by promoting angiogenesis.

Cell research - 1 Sept 2022

Bögürcü-Seidel Nuray, Bergers Gabriele

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glioma
Share to Isocitrate Dehydrogenase
Share to Mutation

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35931821
DOI: 10.1038/s41422-022-00708-9
PMCID: PMC9437032

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

R-2-HG assists IDH1-mutant solid tumors by promoting angiogenesis.PMID 35931821Read ↗

Anticancer drugs: IDH2 drives cancer in vivo.Semantic proximity Read ↗

A new era for glioma therapy - targeting mutant IDH.Semantic proximity Read ↗

HRD1 in human malignant neoplasms: Molecular mechanisms and novel therapeutic strategy for cancerSemantic proximity Read ↗

Vorasidenib- A Paradigm Shift in IDH1- or IDH2-Mutant Low-Grade Glioma Treatment.Semantic proximity Read ↗

Metabolism: IDH2 drives cancer in vivo.Semantic proximity Read ↗

A pharmacogenomic approach validates AG-221 as an effective and on-target therapy in IDH2 mutant AML.Semantic proximity Read ↗

Optimizing Next-Generation AML Therapy: Activity of Mutant IDH2 Inhibitor AG-221 in Preclinical Models.Semantic proximity Read ↗

T cells take aim in AML: targeting IDH2.Semantic proximity Read ↗

IDH1 Arg-132 mutant promotes tumor formation through down-regulating p53.Semantic proximity Read ↗

IDH1 and IDH2: Not Your Typical OncogenesSemantic proximity Read ↗

Mutational profiling of isolated myeloid sarcomas and utility of serum 2HG as biomarker of IDH1/2 mutations.Semantic proximity Read ↗

A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.